These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19860644)

  • 1. The paradox of caffeine-zolpidem interaction: a network analysis.
    Myslobodsky M
    Curr Drug Targets; 2009 Oct; 10(10):1009-20. PubMed ID: 19860644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
    Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.
    Mattila MJ; Nurminen ML; Vainio P; Vanakoski J
    Eur J Clin Pharmacol; 1998 Jul; 54(5):421-5. PubMed ID: 9754987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation.
    Kovacic P; Somanathan R
    Oxid Med Cell Longev; 2009; 2(1):52-7. PubMed ID: 20046645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work.
    Batéjat D; Coste O; Van Beers P; Lagarde D; Piérard C; Beaumont M
    Aviat Space Environ Med; 2006 May; 77(5):515-25. PubMed ID: 16708532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
    Drover DR
    Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midazolam 12 mg is moderately counteracted by 250 mg caffeine in man.
    Mattila MJ; Vainio P; Nurminen ML; Vanakoski J; Seppälä T
    Int J Clin Pharmacol Ther; 2000 Dec; 38(12):581-7. PubMed ID: 11125871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
    Wilkinson CJ
    J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
    Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
    J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the hypnotic zolpidem in vivo.
    Crestani F; Martin JR; Möhler H; Rudolph U
    Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daytime sleep and performance following a zolpidem and melatonin cocktail.
    Wesensten NJ; Balkin TJ; Reichardt RM; Kautz MA; Saviolakis GA; Belenky G
    Sleep; 2005 Jan; 28(1):93-103. PubMed ID: 15700725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells.
    Dragicevic N; Delic V; Cao C; Copes N; Lin X; Mamcarz M; Wang L; Arendash GW; Bradshaw PC
    Neuropharmacology; 2012 Dec; 63(8):1368-79. PubMed ID: 22959965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem.
    Akhondzadeh S; Mohammadi MR; Kashani L
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1161-6. PubMed ID: 12452540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome.
    Cirignotta F; Mondini S; Zucconi M; Gerardi R; Farolfi A; Lugaresi E
    Pharmacol Biochem Behav; 1988 Apr; 29(4):807-9. PubMed ID: 3413202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent].
    Shirakawa K
    Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.